Bacterial infections in cirrhosis: A growing problem with significant implications.
作者信息
Fernandez Javier, Arroyo Vicente
机构信息
Liver Unit, IMDiM, Hospital Clínic, Universidad de Barcelona, IDIBAPS and CIBERehd, Barcelona, Spain.
出版信息
Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):102-105. doi: 10.1002/cld.169. eCollection 2013 Jun.
Abstract
摘要
相似文献
1
Bacterial infections in cirrhosis: A growing problem with significant implications.肝硬化中的细菌感染：一个日益严重且具有重大影响的问题。
Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):102-105. doi: 10.1002/cld.169. eCollection 2013 Jun.
2
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.欧洲失代偿期肝硬化和慢加急性肝衰竭患者中的多重耐药菌感染。
J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2.
3
Bacterial infections in alcoholic and nonalcoholic liver cirrhosis.酒精性和非酒精性肝硬化中的细菌感染
Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1080-6. doi: 10.1097/MEG.0000000000000396.
4
BACTERIAL INFECTIONS IN PATIENTS WITH LIVER CIRRHOSIS.肝硬化患者的细菌感染
Med Pregl. 2015 May-Jun;68(5-6):187-91. doi: 10.2298/mpns1506187p.
5
Bacterial infection-related morbidity and mortality in cirrhosis.肝硬化中与细菌感染相关的发病率和死亡率。
Am J Gastroenterol. 2007 Jul;102(7):1510-7. doi: 10.1111/j.1572-0241.2007.01286.x. Epub 2007 May 17.
6
[Bacterial infections in patients with liver cirrhosis and ascites].
Srp Arh Celok Lek. 2014 Sep-Oct;142(9-10):551-6. doi: 10.2298/sarh1410551m.
7
Bacterial infections in cirrhosis: A critical review and practical guidance.肝硬化中的细菌感染：批判性综述与实用指南。
World J Hepatol. 2016 Feb 28;8(6):307-21. doi: 10.4254/wjh.v8.i6.307.
8
Infection as a Trigger for Portal Hypertension.感染作为门静脉高压的触发因素
Dig Dis. 2015;33(4):570-6. doi: 10.1159/000375352. Epub 2015 Jul 6.
9
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.全球肝硬化患者细菌感染的流行病学和影响。
Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13.
10
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.代偿期和失代偿期肝硬化患者的死亡预测因素：细菌感染及感染相关慢加急性肝衰竭的作用
Scand J Gastroenterol. 2015 Jul;50(7):875-83. doi: 10.3109/00365521.2015.1017834. Epub 2015 Feb 19.
引用本文的文献
1
Bacterial Infections in Patients with Liver Cirrhosis: Prevalence, Predictors, and in-Hospital Mortality at a District Hospital in Ghana.加纳一家区级医院肝硬化患者的细菌感染：患病率、预测因素及住院死亡率
Rwanda J Med Health Sci. 2022 Apr 12;5(1):46-54. doi: 10.4314/rjmhs.v5i1.6. eCollection 2022 Apr.
2
Establishment of a prognostic model for hospitalized cirrhotic patients with infection based on lumbar muscle mass.基于腰大肌质量建立住院感染性肝硬化患者的预后模型
Heliyon. 2024 Feb 8;10(4):e25739. doi: 10.1016/j.heliyon.2024.e25739. eCollection 2024 Feb 29.
3
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Infections in Patients With Liver Cirrhosis.头孢他啶-阿维巴坦用于治疗肝硬化患者的碳青霉烯类耐药感染
J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1293-1300. doi: 10.1016/j.jceh.2022.04.016. Epub 2022 Apr 21.
4
Acute decompensation events differentially impact the risk of nosocomial infections and short-term outcomes in patients with cirrhosis.急性失代偿事件对肝硬化患者医院感染风险和短期预后的影响存在差异。
Front Med (Lausanne). 2022 Aug 17;9:962541. doi: 10.3389/fmed.2022.962541. eCollection 2022.
5
Treatment of Hospital-Acquired Infections in Patients with Cirrhosis - New Challenges.肝硬化患者医院获得性感染的治疗——新挑战
Infect Drug Resist. 2022 Mar 15;15:1039-1048. doi: 10.2147/IDR.S283723. eCollection 2022.
6
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know.抗生素与肝硬化：医生需要了解的内容
Antibiotics (Basel). 2021 Dec 28;11(1):31. doi: 10.3390/antibiotics11010031.
7
Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department.内科肝硬化患者的细菌感染
GE Port J Gastroenterol. 2019 Aug;26(5):324-332. doi: 10.1159/000494568. Epub 2018 Dec 17.
8
An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver Disease.慢性肝病中细菌感染的抗生素耐药性洞察
J Clin Exp Hepatol. 2017 Dec;7(4):305-309. doi: 10.1016/j.jceh.2017.05.003. Epub 2017 May 15.
9
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis.新发革兰氏阳性菌自发性细菌性腹膜炎抗菌治疗的当前概念与未来策略
World J Hepatol. 2017 Oct 28;9(30):1166-1175. doi: 10.4254/wjh.v9.i30.1166.
10
Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.多重耐药病原体时代医院获得性自发性细菌性腹膜炎的抗生素治疗：一项系统评价
World J Gastroenterol. 2017 Jul 7;23(25):4654-4660. doi: 10.3748/wjg.v23.i25.4654.
本文引用的文献
1
Management of bacterial infections in cirrhosis.肝硬化细菌感染的管理。
J Hepatol. 2012;56 Suppl 1:S1-12. doi: 10.1016/S0168-8278(12)60002-6.
2
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.肝硬化患者多重耐药菌感染的患病率及危险因素：一项前瞻性研究。
Hepatology. 2012 May;55(5):1551-61. doi: 10.1002/hep.25532. Epub 2012 Apr 4.
3
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南
J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.
4
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.肝硬化患者的感染会使死亡率增加四倍，应将其用于判断预后。
Gastroenterology. 2010 Oct;139(4):1246-56, 1256.e1-5. doi: 10.1053/j.gastro.2010.06.019. Epub 2010 Jun 14.
5
Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management.肝硬化继发细菌性腹膜炎：临床和分析特征、诊断和治疗的回顾性研究。
J Hepatol. 2010 Jan;52(1):39-44. doi: 10.1016/j.jhep.2009.10.012. Epub 2009 Oct 23.
6
Management of adult patients with ascites due to cirrhosis: an update.肝硬化所致成人腹水患者的管理：最新进展
Hepatology. 2009 Jun;49(6):2087-107. doi: 10.1002/hep.22853.
7
Bacterial infections, sepsis, and multiorgan failure in cirrhosis.肝硬化中的细菌感染、脓毒症及多器官功能衰竭
Semin Liver Dis. 2008 Feb;28(1):26-42. doi: 10.1055/s-2008-1040319.
8
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.自发性细菌性腹膜炎的一级预防可延缓肝肾综合征并提高肝硬化患者的生存率。
Gastroenterology. 2007 Sep;133(3):818-24. doi: 10.1053/j.gastro.2007.06.065. Epub 2007 Jul 3.
9
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.诺氟沙星与头孢曲松预防晚期肝硬化合并出血患者感染的比较
Gastroenterology. 2006 Oct;131(4):1049-56; quiz 1285. doi: 10.1053/j.gastro.2006.07.010.
10
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.静脉输注白蛋白对肝硬化合并自发性细菌性腹膜炎患者肾功能损害及死亡率的影响。
N Engl J Med. 1999 Aug 5;341(6):403-9. doi: 10.1056/NEJM199908053410603.
Zotero 插件